Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-09Evaluation of Executive Function With Static and Dynamic Shopping Assignment in Virtual Reality Among People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-05-0550 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-05-03Past Pain Experience and Perception of Experimental Pain
-
CLINICAL_TRIALS study record update · 2017-05-01A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of TAK-058 and Ondansetron on P50 Auditory Gating in Subjects With Stable Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-04-28A Double Blind Placebo Controlled Trial of the Effects of Transdermal Nicotine on Cognitive Function in Non-Smokers With and Without Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-25The Effect of a Community-based Long-acting Antipsychotic-treated Management Model on the Violence Risk of Patients With Schizophrenia: a 1-year, Open-label Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2017-04-19Rationalisation of Antipsychotic Drug Use in Older People, Using [18F]-Fallypride PET
-
CLINICAL_TRIALS study record update · 2017-04-19Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging
-
CLINICAL_TRIALS study record update · 2017-04-19A Phase I, Double-Blind, Randomized, Multiple-Dose, Pilot Study Comparing Xanomeline Administered Alone to Xanomeline Administered in Combination With Trospium Chloride in Normal Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2017-04-18Oxytocin Treatment of Social Deficits and Paranoia in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-04-12Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
-
CLINICAL_TRIALS study record update · 2017-04-11Clinical and Biomarker Assessment of Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
-
CLINICAL_TRIALS study record update · 2017-04-10CAD Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation
-
CLINICAL_TRIALS study record update · 2017-04-04Patient Guided Psychiatric Admissions (Self-referral to Inpatient Beds)
-
CLINICAL_TRIALS study record update · 2017-03-29A Sequential and Parallel Cohort Design to Test the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
-
CLINICAL_TRIALS study record update · 2017-03-29Physiological and Psychiatric Effects From Aerobic High Intensity Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia: A Controlled Clinical Trial.
-
CLINICAL_TRIALS study record update · 2017-03-27A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-03-24Add-on Simvastatin in Schizophrenia Trial
-
CLINICAL_TRIALS study record update · 2017-03-23A Multi Centre, Double-Blind, Double-Dummy, Placebo-Controlled, Randomised, Adaptive, Dose-Range Study To Evaluate the Safety and Efficacy of SB-773812 Administered Once Daily for 12 Weeks in Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-03-23Effect of Atypical Antipsychotics on Gene Expression in Soft Tissues of Healthy Subjects - A Placebo Controlled Randomised Pilot Study
-
CLINICAL_TRIALS study record update · 2017-03-23The Improving Care and Reducing Cost (ICRC) Program
-
CLINICAL_TRIALS study record update · 2017-03-22A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Evaluate The Efficacy and Safety of Lurasidone in Adolescent Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-03-14Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-episode Non-affective Psychosis Individuals: A 3-year Follow-up
-
CLINICAL_TRIALS study record update · 2017-03-14Phase IV Study of Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in the Treatment of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program II (PAFIP II): a 3-year Follow-up
-
CLINICAL_TRIALS study record update · 2017-03-14Pilot Study of the Feasibility of a Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia